Vital Therapies reported $4.12M in Trade Debtors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
Dynavax Technologies DVAX:US $ 105.9M 21.91M
Enanta Pharmaceuticals ENTA:US $ 21.62M 1.49M
Epizyme EPZM:US $ 7.12M 2.64M
Insmed INSM:US $ 18.42M 789K
Intercept Pharmaceuticals ICPT:US $ 45.25M 2.66M
Mirati Therapeutics MRTX:US $ 67.12M 65.28M
Omeros OMER:US $ 31.84M 7.01M
Orasure Technologies OSUR:US $ 35.26M 1.13M
Quidel QDEL:US $ 85.62M 19.91M
Regulus Therapeutics RGLS:US $ 0.19M 0.12M
Revance Therapeutics RVNC:US $ 641K 4.54M
Ultragenyx Pharmaceutical RARE:US $ 24.72M 0.31M
United Therapeutics UTHR:US $ 173.4M 32.3M
Vital Therapies VTL:US $ 4.12M 3.82M
Xoma XOMA:US $ 12K 68K